India's Neuland Laboratories rises as U.S. FDA inspection ends with no observations

Neuland Laboratories

29/11/2018 09:28

** Neuland Laboratories Ltd's  NEUL.NS  shares jump 13.9 pct
to 558.95 rupees in their sharpest intraday pct climb since Oct
4, 2017
    ** U.S. FDA's inspection of co's manufacturing facility at
Pashmylaram in South India from Nov. 26-29 was completed with no
observations, co said on Thursday  urn:newsml:reuters.com:*:nFWN1Y312S
    ** Stock touches highest since Nov. 12; about 140,000 shares
change hands, compared with the 30-day moving avg of 9,900
shares
    ** Stock down 45.1 pct this year as of last close

 ((Reuters Messaging:
chris.thomas.thomsonreuters.com@reuters.net))